Currently, there are limited supplies of the reagents used for HIV-1 Western Blot and HIV-2 EIA testing. In order to conserve the remaining reagent, a controlled process of batch testing was implemented. Therefore, you will likely see additional delays in receiving these supplemental test results.
Read about our plan to mitigate this on the Communications page by clicking this link: Communications
As a friendly reminder, airlines often change their routine flights and cargo hours for hol...
On April 29, 2019, CTS will begin performing Donor-Screen HLA® Class I and II testing on the Str...
Dr. Buff Mair is the new CTS Medical Director and replaces Dr. German Leparc who retired at the begi...
We sincerely hope to see you at this year’s AABB Annual Meeting in San Antonio, TX on October ...
We are informing you that the FDA has announced their withdrawal of Guidance for ZIKV Testing. In th...
That’s just one of the reasons that National Blood Donor Month, which has taken place each Jan...